Advanced Research Center Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Advanced Research Center's estimated annual revenue is currently $6.3M per year.(i)
  • Advanced Research Center's estimated revenue per employee is $91,800

Employee Data

  • Advanced Research Center has 69 Employees.(i)
  • Advanced Research Center grew their employee count by 6% last year.

Advanced Research Center's People

NameTitleEmail/Phone
1
VP Recruiting & Patient ExperienceReveal Email/Phone
2
Director Finance And AccountingReveal Email/Phone
3
Clinical Research Associate ManagerReveal Email/Phone
4
Senior Manager, Clinical ExecutionReveal Email/Phone
5
General ManagerReveal Email/Phone
6
Staff AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24M21410%N/AN/A
#2
$4.8M52-4%N/AN/A
#3
$2.9M369%N/AN/A
#4
$22.4M2005%N/AN/A
#5
$1.7M249%N/AN/A
#6
$10.1M99-1%N/AN/A
#7
$5.8M639%N/AN/A
#8
$3.2M39N/AN/AN/A
#9
$5.8M63-3%N/AN/A
#10
$0.8M13N/AN/AN/A
Add Company

What Is Advanced Research Center?

Here at ARC we are committed to building a healthy community and advancing personalized and precision medicine. Together, we can move towards a future where the drug, disease, and person are aligned in treatment towards healthy outcomes. Our research sites operate a wide range of FDA-approved studies with staff members who are devoted to improving community medicine. We aim to shorten the gap between clinical research and drug delivery for healthy patient outcomes. Business Hours: Monday-Friday: 9am-5pm, PST Phone: 714-999-6688, (877) 860-3095 (Toll Free) Fax: 714-908-1555 www.arctrials.com www.facebook.com/arctrials For more information contact us by email arc_partners@arctrials.com

keywords:N/A

N/A

Total Funding

69

Number of Employees

$6.3M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18M69-4%N/A
#2
$21.9M69-4%N/A
#3
$19.9M696%N/A
#4
N/A69-1%N/A
#5
$13.2M7040%N/A